LEP and breast cancer: A range of signaling mechanisms, including IL-6, IGF-1, leptin, and adiponectin, have been proposed to explain how mature adipocytes alter breast cancer cell behavior [45, 46, 56, 57], but the role of adipocyte-derived fatty acids as direct metabolic substrates has not been investigated.